LIXUMISTAT
UNII 4G3BUV6ZSK

Substance Identification & Data

This profile provides standardized clinical and technical data for Lixumistat, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4G3BUV6ZSK.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1422365-93-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

4G3BUV6ZSK

CAS Registry Number

1422365-93-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LIXUMISTAT

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C13H16F3N5O

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

NGFUHJWVBKTNOE-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C201972

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

71512108

Unique identification number in the NCBI database of chemical substances.

INN ID

12701

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1c(ccc(c1)NC(=N)NC(=N)N2CCCC2)OC(F)(F)F

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lixumistat. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.